Rathbones Group PLC Sorrento Therapeutics, Inc. Transaction History

Rathbones Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$7.41 - $10.99 $302,209 - $448,216	-40,784 Closed	0 $0
Q2 2021 Jul 30, 2021	SELL	$6.35 - $10.0 $10,795 - $17,000	-1,700 Reduced 4.0%	40,784 $395,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $18,510 - $56,460	-3,000 Reduced 6.6%	42,484 $474,000
Q2 2020 Aug 07, 2020	SELL	$1.73 - $6.76 $2,249 - $8,788	-1,300 Reduced 2.78%	45,484 $286,000
Q1 2020 May 04, 2020	SELL	$1.57 - $4.76 $23,550 - $71,400	-15,000 Reduced 24.28%	46,784 $86,000
Q3 2019 Nov 13, 2019	BUY	$2.05 - $2.69 $126,657 - $166,198	61,784 New	61,784 $132,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

Stay updated on Rathbones Group PLC with notifications on news.